Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study.

CONCLUSION: Belimumab along with rituximab showed promising results in refractory patients with CV.
PMID: 33248866 [PubMed - as supplied by publisher]

Source: Journal of Autoimmunity - November 25, 2020 Category: Allergy & Immunology Authors: Saadoun D, Ghembaza A, Riviere S, Mekinian A, Boutemy J, Leroux G, Domont F, Maillard H, Vautier M, Cacoub P Tags: J Autoimmun Source Type: research